Bourdow Carrie L.
- SEC CIK
- 0001638989
No open-market purchases or sales filed in the past year.
Current role at each company
- TRVN Trevena IncActing CEOas of Oct 10, 2024
- Nabriva Therapeutics plcDirectoras of Aug 3, 2022
- CARM Carisma Therapeutics Inc.Directoras of Jun 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bourdow Carrie L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
Nabriva Therapeutics plc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 (view filing)9:47 PM ET | Aug 1 | 2 days | Bourdow Carrie L.Director | SSale | −8.54K | $0.1741 | −$1.49K | −46.2%9.93K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Bourdow Carrie L.Director | SSale | −777 | $1.20 | −$932.4 | −4.0%18.5K after |